{"schema_version":"secwatch.filing_event.v1","accession":"0001297184-22-000026","form_type":"8-K","ticker":"AMPH","cik":"0001297184","company_name":"Amphastar Pharmaceuticals, Inc.","filed_at":"2022-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.121391+00:00","generated_at":"2026-06-25T22:16:25.250762+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Amphastar Q1 2022 revenue $120.4M (+17% YoY); GAAP EPS $0.47 vs $0.10","bullets":["Net revenues $120.4M for Q1 2022, up from $103.0M in Q1 2021 (+17% YoY).","GAAP net income $24.3M ($0.47 diluted EPS) vs $5.0M ($0.10) a year ago.","Adjusted non-GAAP net income $24.6M ($0.47 EPS) vs $13.6M ($0.27) in Q1 2021.","CEO cites strong sales of recent complex product launches; optimistic for continued growth."],"urls":{"canonical":"https://secwatch.observer/filing/0001297184-22-000026","json":"https://secwatch.observer/filing/0001297184-22-000026.json","markdown":"https://secwatch.observer/filing/0001297184-22-000026.md","text":"https://secwatch.observer/filing/0001297184-22-000026.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1297184/000129718422000026/0001297184-22-000026-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1297184/000129718422000026/amph-20220509x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T22:16:25.250762+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}